Jeffrey T. Walsh's most recent trade in Tenaya Therapeutics Inc was a trade of 107,400 Stock Option (Right to buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) |